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Repaglinide is a novel prandial glucose regulator for. the treatment of type 2 diabetes
mellitus (Natrass, 2000; Hatorp et. at., 2003).The primary aim of the study was to deyelop
and validate a rapid High Perfonnance Liquid Chromatography (HPLC) method for
detemlination of repaglinide in human plasma. The developed method was then l;i.pplied to a
phannacokinetic study of 4mg dose of repaglinide in 52 healthy volunteers. The study
protocols were approved by Universiti Sains Malaysia Ethics Committee.
Following a liquid-liquid extraction using ethylacetate at pH 7.4, samples were separated
by HPLC. The method was validated with respect to linearity, range, precision, accuracy,
recovery, selectivity and stability (eDER, 2001).-<
The calibration curve was linear over the concentration range of 20-200 ng/ml. The limits
of detection and quantification were 10 ng/ml and 20 ng/ml, respectively. Mean recovery
for repaglinide was 89.73 ± 7.31. The inter-day (n;;::9) precision was from 9.47% to 11.96%
and the intra-day (n::::3) precision ranged from 1.95% to 5.01% (Table 1). The inter-day
(n=9) accuracy ranged 89.58% to 101.85% and intra-day (n;;::3) accuracy ranged from
85.53%to 99.18% (Table 1) (see below).
Concentration Mean SD Precision Accuracy (%)
(ng/rol) (ng/ml) (CY)
Repaglinide Interday (Between batch) (n=9)
40 38.16 3.62 9.47 95.41
70 71.29 8.53 11.96 101.85
150 134.37 15.30 r 11.38 89.58
Repaglinide Intraday (Within batch) (n=3)
40 38.17 1.91 5.01 95.44
70 69.43 1.36 1.95 99.18
150 128 3.98 3.11 85.53
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A rapid, simple and reproducible HPLC method for the detennination of repaglinide in
human plasma has been developed and validated. This method has been successfully used
_ " to study repaglinide pharmacokinetics in healthy volunteers. ,
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